Haii

Leading Digital Biomarker company trusted by clinicians and patients worldwide

Seoul, South Korea · Founded 2016 · $5.5M raised

Headquarters
Seoul
Employees
51–200
Founded
2016
Business Model
B2B
Website
haii.io
Total Funding
$5.5M
Last Round
$5.5M Seed
Rounds
1

About

HAII Corp. (Human AI Interaction) is a Seoul-based digital health company advancing diagnostics, therapeutics, and monitoring through AI-driven digital biomarkers. Founded in 2016, the company develops software-based treatments for mental health and neurological conditions, including AnzeiLax (a digital therapeutic for General Anxiety Disorder), MindCheck (a smartphone-based HRV and mental wellness assessment), and stroke rehabilitation tools. HAII's platform uses a 43-second smartphone scan to detect biomarkers from voice, eye-tracking, and facial data — replacing or supplementing clinical diagnostics. The company has received regulatory recognition from South Korea's NECA and has active clinical trials in the United States. HAII has been recognized with the KHF 2025 Innovation Award and describes its mission as building the "Pfizer of Digital Therapeutics." It serves both individual patients and organizations seeking science-based emotional care solutions.

Summary

Haii is an Artificial Intelligence company based in Seoul, South Korea, founded in 2016. It has raised $5.5M in total across 1 round. Investors include CJ Investment.

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed Round
$5.5M

Investors

Similar Companies